Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis

Bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic SCT (HSCT) is recognized as a new-onset obstructive lung defect (OLD) in pulmonary function testing and is related to pulmonary chronic GVHD. Little is known about the different phenotypes of patients with BOS and their outcomes....

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Bone Marrow Transplant
Autores principales: Bergeron, A, Godet, C, Chevret, S, Lorillon, G, Peffault de Latour, R, de Revel, T, Robin, M, Ribaud, P, Socié, G, Tazi, A
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group UK 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7091913/
https://ncbi.nlm.nih.gov/pubmed/23208317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2012.241
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares